{"id":"W2520692458","doi":"10.1016/j.ctrv.2016.09.001","title":"Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Irinotecan; Oxaliplatin; Gemcitabine; Internal medicine; Oncology; Pancreatic cancer; Clinical trial; Randomized controlled trial; FOLFIRINOX; Population; Context (archaeology); Progression-free survival; Cancer; Colorectal cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005520123,0.001203797,0.02942642,0.0002456406,0.0001341525,0.00001787359,0.0002009463,0.0002645329,0.0008874944],"category_scores_gemma":[0.003783811,0.0004809701,0.001999455,0.0003846002,0.0004058025,0.0001078176,0.00004701054,0.000237891,0.00001081217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001437676,"about_ca_system_score_gemma":0.004071863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001561773,"about_ca_topic_score_gemma":0.00003469074,"domain_scores_codex":[0.9899158,0.003828307,0.004029387,0.001007237,0.000566712,0.0006525033],"domain_scores_gemma":[0.9827788,0.009955685,0.005013719,0.000855884,0.001085599,0.0003103181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04071245,0.0003688866,0.0002139787,0.1048094,0.005558843,0.000003633932,0.0002384217,3.529307e-8,0.000001837195,0.0000123242,0.0003188568,0.8477613],"study_design_scores_gemma":[0.1098226,0.007476679,0.00001665185,0.3956545,0.02330335,0.000008588369,0.00001247458,0.000005067322,0.000001887937,0.00000531885,0.4633411,0.0003518431],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003323918,0.9417443,0.0000500532,0.0002591239,0.0001494129,0.05627081,0.0007937952,0.00002897322,0.0003711577],"genre_scores_gemma":[0.000006452645,0.9264066,0.003418297,0.0003017728,0.0002471771,0.06601657,0.0004869272,0.00009951211,0.00301664],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8474095,"threshold_uncertainty_score":0.9997642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.30522861975147,"score_gpt":0.5399468667520916,"score_spread":0.2347182470006216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}